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Abstract
Thermal neutrality in rodents is achieved by large cyclic variations of the
sympathetic drive of the vasomotion of the tail and paws, the most widely used
target organs in current acute or chronic animal models of pain. Given the pivotal
functional role of rostral ventromedial medulla (RVM) in nociception and rostral
medullary raphe (rMR) in thermoregulation, two largely overlapping brain regions,
we aimed at circumscribing the brainstem regions that are the source of premotor
afferents to sympathetic preganglionic neurons that control the vasomotor tone
of the tail and hind paws. A thermometric infrared camera recorded indirectly
the vasomotor tone of the tail and hind paws. During the control period, the
rat was maintained in vasoconstriction by preserving a stable, homogeneous,
and constant surrounding temperature, slightly below the core temperature. The
functional blockade of the RVM/rMR by the GABAA receptor agonist muscimol
(0.5 nmol, 50 nl) elicited an extensive increase of t...
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Thermal neutrality in rodents is achieved by large cyclic variations of the
sympathetic drive of the vasomotion of the tail and paws, the most widely
used target organs in current acute or chronic animal models of pain.
Given the pivotal functional role of rostral ventromedial medulla (RVM)
in nociception and rostral medullary raphe (rMR) in thermoregulation,
two largely overlapping brain regions, we aimed at circumscribing the
brainstem regions that are the source of premotor afferents to sympathetic
preganglionic neurons that control the vasomotor tone of the tail and hind
paws. A thermometric infrared camera recorded indirectly the vasomotor
tone of the tail and hind paws. During the control period, the rat was
maintained in vasoconstriction by preserving a stable, homogeneous, and
constant surrounding temperature, slightly below the core temperature.
The functional blockade of the RVM/rMR by the GABAA receptor
agonist muscimol (0.5 nmol, 50 nl) elicited an extensive increase of the
temperature of the paws and tail, associated with a slight decrease of
blood pressure and heart rate. Both the increased heat loss through
vasodilatation and the decrease heart-induced heat production elicited a
remarkable reduction of the central temperature. The effective zones were
circumscribed to the parts of the RVM/rMR facing the facial nucleus.
They match very exactly the brain regions often described as specifically
devoted to the control of nociception. Our data support and urge on the
highest cautiousness regarding the interpretation of results aimed at
studying the effects of any pharmacological manipulations of RVM/rMR
with the usual tests of pain.
rat; thermoregulation; ambient temperature; skin temperature; envi-
ronmental impact; blood pressure; heart rate; infrared camera; rostral
ventromedial medulla; RVM; rostral medullary raphe; rMR
NUMEROUS STUDIES HAVE EXPLORED the descending systems that
control the spinal transmission of nociceptive messages, nota-
bly through the rostral ventromedial medulla (RVM) in the
brainstem. The RVM includes the nucleus raphe magnus and
the neighboring part of the reticular formation, which extends
under the gigantocellular reticular nucleus (Fields et al. 2006).
Two main categories of neurons, so-called “on-” and “off-”
cells, were highlighted that 1) exhibit irregular spontaneous
activities in opposition of phase (Barbaro et al. 1989) and 2)
are activated and inhibited by nociceptive stimuli, respectively
(Fields et al. 1983; Vanegas et al. 1984). These two neuronal
types were proposed to belong to a double spino-bulbo-spinal
positive feedback loop that facilitates the spinal transmission of
nociceptive messages, either directly or through a mechanism
of disinhibition, the on- and off-cells being supposed to pro-
duce an excitatory and an inhibitory drive on the spinal
neurons, respectively.
However, RVM neurons could play a much less specific role
than that of a descending pathway modulating nociception at
spinal level (Le Bars et al. 2001; Lefler et al. 2008; Lovick
1997; Mason 2001, 2005a,b, 2006, 2011, 2012; Thurston and
Helton 1996; Thurston and Randich 1992, 1995). For example,
we described recently the probable involvement of on- and
off-cells in autonomic regulation, notably thermoregulation (El
Bitar et al. 2014b).
On the basis of three animal models used in thermoregula-
tion studies, namely the tail of the rat, the ear of the rabbit, and
the interscapular brown adipose tissue (BAT) of the rat, it
became apparent that neurons in the midline region of the
ventral medulla play a critical role in responding to cold
(Blessing et al. 1999; McAllen et al. 2010; Morrison 1999,
2011; Morrison et al. 1999, 2008, 2012; Nakamura 2011;
Nakamura and Morrison 2008, 2011; Rathner et al. 2001;
Rathner and McAllen 1999; Tanaka et al. 2002). Broadly,
cooling the animal results in 1) reduced heat loss through
increased skin vasoconstriction of the ear in the rabbit or the
tail in the rat and 2) increased heat production by BAT in the
rat. These phenomena are triggered by activation of sympa-
thetic preganglionic neurons in the spinal intermediolateral cell
column, themselves under the control of premotor neurons
located in the rostral medullary raphe (rMR), a region imme-
diately rostral to the rostral pole of the inferior olivary com-
plex, that includes the raphe pallidus, the raphe magnus, and
the laterally extending parapyramidal nucleus (Blessing 2003;
McAllen et al. 2010; Morrison 2011; Nakamura 2011; Naka-
mura and Morrison 2008, 2011), where the expression of Fos
immunoreactivity is increased following cold exposure (Bonaz
and Taché 1994; Cano et al. 2003; Morrison et al. 1999;
Nakamura et al. 2004).
Yet a possible discrepancy was noted. Studies focusing on
the descending systems postulated to control nociception em-
phasize a region that includes the nucleus raphe magnus and
the gigantocellular reticular nucleus pars alpha, mainly at the
level of the facial nucleus (e.g., Brink et al. 2006; Carlson et al.
2007; Fields et al. 1995; Heinricher and Kaplan 1991; Hei-
nricher and Tortorici 1994; Kaplan and Fields 1991; Morgan
and Fields 1994; Neubert et al. 2004; Vanegas et al. 1984;
Thurston and Helton 1996; Thurston and Randich 1995; Xu et
al. 2007), while studies focusing on thermoregulation empha-
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size a slightly more caudal region including the raphe pallidus
(e.g., Blessing and Nalivaiko, 2001; Cao and Morrison 2003;
Cao et al. 2004, 2010; Cerri et al. 2010; Fan et al. 2007;
Madden and Morrison 2003, 2005; Morrison 1999, 2003,
2004; Morrison et al. 1999, 2000; Nakamura and Morrison
2007, 2011; Nakamura et al. 2004; Ootsuka and McAllen
2005; Rathner et al. 2001, 2008; Salo et al. 2009; Tanaka et al.
2002, 2007; Yoshida et al. 2003).
The aim of the present study was therefore to exactly map
the brainstem regions that contain the premotor sympathetic
neurons controlling the vasomotor tone of the tail and hind
paws of the rat and to compare these locations with that of
nociception-related brainstem areas. This choice was made
specifically because many behavioral models of pain/nocicep-
tion are based on the assessment of the response of a rodent to
a thermal stimulus applied to the tail or a hind paw (reviewed
in Le Bars et al. 2001, 2009).
Specifically, we measured in 160 adult male Sprague-Daw-
ley rats the dynamic changes in vasomotor tone induced by
microinjections of muscimol within these regions. During the
injection, the rats were maintained in a stable state of tail and
hind paw vasoconstriction. Microinjection of muscimol within
the RVM/rMR was expected to elicit vasodilation of the tail
and hind paw. When a vasomotor response was present, the
latency at which vasodilation occurred was used as an index of
the distance between the injection site and the structure gen-
erating the response.
Glossary
 Slope of the squared temperature variation
elicited by a radiant heat source (°C2/s)
bpm Beats per minute
t Duration of the ascending phases of vasodila-
tation ( tmax  tmin)
paw-contra Mid-plantar area on the hind paw, contralat-
eral to the injection site
paw-ipsi Mid-plantar area on the hind paw, ipsilateral
to the injection site
tmin Beginning time of the ascending phase of
vasodilatation (min)
tmax End time of the ascending phase of vasodila-
tation (min)
tx Abscissa of the inflection point of Boltzmann
sigmoid (min)
Tadj Sigmoid Boltzmann curve adjusted to the re-
corded temperature
Tmax Adjusted maximal skin temperature at the end
of the process of vasodilatation (°C)
Tmin Adjusted skin temperature during the control
period (°C)
Tskin Temperature of the skin (°C)
Tx Ordinate of the inflection point of Boltzmann
sigmoid (°C)
x Latero-lateral coordinate with reference to the
interaural line
y Ventrodorsal coordinate with reference to the
interaural line
z Rostrocaudal coordinate with reference to the
interaural line
METHODS
Ethic statement. Animal experiments were performed with permis-
sion of the Board of the Veterinarian Services of the French Ministry
of Agriculture (Permit No. 75–151) in accordance with the National
Institutes of Health Guide for the Care and Use of Laboratory
Animals, the European Communities Council Directive 86/609/EEC
regulating animal research, and the Ethics Committee of the Interna-
tional Association for the Study of Pain (Covino et al. 1980; Zim-
mermann 1983). The Ethics Committee in Animal Experiment
Charles Darwin approved the procedures.
Animals. Experiments were performed on 160 adult male
Sprague-Dawley rats (Janvier Labs, Saint-Berthevin, France)
weighing 320 –370 g. They were housed in groups of three to four
per cage, allowed free access to food and water with a 12-h
alternating light-dark cycle, and acclimatized to the laboratory for
at least 1 wk before the experiment. The experiments were con-
ducted between 9 AM and 5 PM.
Experimental procedure. The animals were deeply anesthetized
with 2.5% halothane in 100% oxygen. A tracheal cannula was inserted
and the ventilation was controlled mechanically with an open circuit
respirator equipped with a scavenging system, at a rate of 50 breaths/
min. The tidal volume was adjusted to maintain a normal end-tidal
CO2 (ETCO2). The expiratory halothane level and ETCO2 were
assessed with a capnometer (Capnomac II, Datex Instruments, Hel-
sinki, Finland), recorded each 10 s and under control of alarms
throughout the experiment. The mean arterial blood pressure (MAP)
and heart rate (HR) were monitored continuously via a catheter
inserted into the common carotid artery and connected to a computer
via a transducer. MAP and HR were calculated and recorded using the
NOTOCORD blood pressure analyzer system.
The body of the animal was wrapped up in a water-warming pad
connected to an extra-capacity water circulator (TP 220-Kent; Scien-
tific) sparing the head, the paws, and the tail. The heating blanket was
covered with an isothermic metalized polyester film (“survival blan-
ket”) to stabilize the space temperature around the body. A two-
channel OMEGA HH506RA digital thermometer and two VIP-T-
CT25515 Probes (0.1°C resolution) were used to measure the core
temperature Tcore (throughout a rectal probe inserted 10 cm) and the
heating temperature Twarm (probe placed between the warming pad
and the trunk of the rat). We adjusted Twarm to maintain 1) Tcore stable
within normal physiological values and 2) the tail and hind paws in
vasoconstriction.
The rat was mounted on a Horsley-Clarke stereotaxic frame. The,
0.5 ml of xylocaine 2% was injected subcutaneously in the scalp,
followed by a 2-cm midline incision. After trepanation, a small
incision of the dura mater was made to introduce the tip of a
microinjection glass needle.
After surgery, halothane was decreased to 0.8–0.9% with oxygen
being kept at 100%, the tidal volume was adjusted to keep the ETCO2
around 3.5% and there was a wait of at least 30 min before the
experimental procedure was started. After 15-min of control period in
steady vasoconstriction, 57 ng (50 nl) muscimol were injected in the
RVM/rMR (target zone between 0.8 and 3.3 rostral to interaural
line) over 60 s. Since RVM and rMR largely overlap, we will refer to
“RVM/rMR” for brain regions that include the raphe pallidus, raphe
magnus, parapyramidal nucleus, and the reticular formation that
extends under the gigantocellular reticular nucleus (Mason 2001,
2005a,b, 2006, 2011). Control experiments were conducted with the
same procedure, except that muscimol was injected outside the
RVM/rMR.
Experimental conditions. The experiments were made in anesthe-
tized rat with unremitting halothane level [0.85 (0.83–0.86)%], while
ventilation was controlled to achieve a stable and normal acid-base
equilibrium during the control period ETCO2  3.65 (3.57–3.73)%.
The mean room temperature Tamb was stable at 24.2 (24.1–24.4)°C.
The paws and tail of the rat were maintained in vasoconstriction
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during the control period by preserving a stable, homogeneous and
constant surrounding temperature [Twarm  37.4 (37.2–37.5)°C], 
0.3°C below Tcore [37.7 (37.6–37.8)°C], and kept constant till the end
of the experiment. In the control period, MAP and HR were 83.9
(77.4–90.4) mmHg and 321 (309–332) bpm, respectively.
Muscimol preparation. We prepared muscimol solution in a con-
centration of 0.01 nmol/nl, added pontamine sky blue to identify the
site of injection, fractioned the solution in 2 l aliquots for single use,
and preserved them at 20°C. Muscimol produces a rapid and
persistent hyperpolarization of neurons (Hikosaka and Wurtz 1985;
Martin and Ghez 1999) based on its high affinity and selectivity for
the GABAA receptor (Beaumont et al. 1978; Enna and Snyder 1975;
Gallagher et al. 1983; Krogsgaard-Larsen et al. 1977; Nicholson et al.
1979). The day of the experiment, we filled the circuit of the glass
needle with paraffin to wash out air bubbles, aspirated 0.5 l of
muscimol solution at the tip of the needle using a 1-l Hamilton
syringe, and introduced the needle in the brain at the end of the
surgery.
Thermographic recordings. Under stable environmental tempera-
ture, skin temperature is a reliable indicator of skin blood flow
variations (El Bitar et al. 2014a; Hertzman 1953). Heat transmission
from deeper tissue to the skin occurs by conduction and vascular
convection, and then heat dissipation to the environment occurs
through conduction, convection, evaporation, and radiation processes.
The spatial and temporal evolution of the skin temperature at the level
of the tail and paws was monitored using a JADE MWIR (3- to 5-m
optical bandpass) camera (CEDIP Infrared Systems) with a 500-s
integration time, which supplied images of 320  240 pixels at 1 Hz
with a sensitivity of 0.02°C at 25°C. The camera was placed 1.5 m
upright to the scene and was controlled by the software Cirrus (CEDIP
Infrared Systems). It was calibrated by means of a black body as
previously described (Benoist et al. 2008).
Recently, we verified the highly significant positive linear correla-
tion between skin temperature and skin blood flow measured by a
laser-Doppler probe. The mean time lag between vasodilatation and
skin temperature increase was estimated at around half a minute (El
Bitar et al. 2014a). Such an approach based on thermal imaging has
the advantage of giving accurate measures of temperature at both
temporal and spatial levels.
Analysis of the thermographic films was made using the software
Altair (CEDIP Infrared Systems, Croissy-Beaubourg, France). Ten
regions of interest (ROIs) were defined in the recorded scene, each
comprising 10 pixels. Five ROIs were located on the dorsal aspect of
the tail. A proximal ROI (tail-prox) was placed 3 cm from the root
of the tail, an intermediate ROI (tail-mid) was placed at the middle
of the tail, and a distal ROI (tail-distal) was placed 3 cm from the
tip of the tail. The remaining two zones were distributed equidis-
tantly between tail-prox and tail-mid and tail-mid and tail-dist.
Two additional ROIs were located on the plantar aspect of each
hind paw; their final designation was defined respective to the side
of muscimol microinjection, ipsilateral (paw-ipsi) or contralateral
(paw-contra), as determined following histological controls. Fi-
nally, a ROI was located over a piece of wood placed in the scene
to monitor the ambient temperature (Tamb). For each time point, the
mean of the 10 pixels defining each ROI was computed to obtain
one single temperature time course for each ROI (Ttail-prox,
Ttail-mid, Ttail-dist, Tpaw-left, Tpaw-right, and Tamb).
Histological identification of microinjection sites. At the conclu-
sion of the experiment, the rat was deeply anesthetized with 3%
halothane and the brain was perfused through the heart with 0.9%
NaCl, followed by 10% formaldehyde and removed. The brain was
frozen, cut in serial 100-m thick sections, and Nissl-stained with
cresyl violet or carmin. Sites of microinjections were determined
from microscopic visualization of the serial sections and reported
on schemas of frontal sections of the brain (Paxinos and Watson
1986). Coordinates were then expressed relative to the interaural
line: x-axis  latero-lateral; y-axis  ventrodorsal; and z-axis 
rostrocaudal. The center of injection was easy to delimit. On
average 1 h postinjection, the overall rostrocaudal diffusion of
pontamine blue was 1.1 (1.0 –1.2) mm, that is two times longer
than in the coronal plane.
Assessing the dynamic effects of muscimol on skin temperature.
The skin temperature evolution following muscimol microinjection
matched a sigmoid curve. The curves were adjusted to a Boltzmann
sigmoid according to the equation Tadj  Tmin  Tskin/{1  exp[
(t  tx)/s]}, using the SigmaPlot software. Time t  0 corresponded
to the end of the microinjection (Fig. 1A). The following parameters
were fitted to the data: Tmin (adjusted skin temperature during the
control period), Tmax (adjusted maximal skin temperature at the end of
the process), Tskin  Tmax  Tmin (amplitude of the skin tempera-
ture variation), tx (abscissa of the inflection point of the sigmoid), Tx
(ordinate of the inflection point of the sigmoid), and s  spread of the
sigmoid curve. These parameters were calculated for the proximal and
distal parts of the tail and for each hind paw. The regression coeffi-
cients R2 of the adjusted curves were always highly significant
(	0.98).
The regulation of the laboratory air-conditioning system was a
source of change of Tamb in the  0.5°C range. This represented
10% of the magnitude of the ascending phase of muscimol-induced
increases in skin temperature at the hind paws and distal part of the
tail and 15% of the increases in skin temperature at the proximal
tail. Therefore, the beginning (tmin) of the ascending phase of vaso-
dilatation at the hind paws and distal part of the tail was calculated by
considering the 10% percentile of Tskin: tmin  tx 
s  Ln(1/0.1–1) (Fig. 1B). A slightly different cutoff (15%) was
chosen to estimate the onset of vasodilation at the proximal part of the
tail, because of the slower evolution of the process at that location.
The end (tmax) of the ascending phase of vasodilatation was calculated
by considering the 90% percentiles of Tskin: tx  s  Ln(1/0.9–1).
Then, the latency of the vasomotor reactions were divided into
three groups according to the distribution of the beginning time tmin of
the ascending phase of vasodilatation: tmin
 7.5 min, 7.5
 tmin
 15
min and tmin 	 15 min. This categorization was justified by the clear
bimodal distribution of tmin, centered on 3–5 and 10–12 min, respec-
tively (Fig. 1C). Beyond 15 min, the distribution of tmin was flat, and
the observed effects if any were interpreted as resulting from uncon-
trolled diffusion of muscimol (Edeline et al. 2002). Together with a
small volume of injection (50 nl) and a large number of negative sites
of injection, this approach provided an acute delineation of the
structures controling sympathetic cutaneous vasoconstrictor activity.
Three-dimensional mapping of response latencies. The large num-
ber of microinjection sites provided the opportunity of building a
three-dimensional mapping of response latencies as a function of
injection site, using interpolation. The interpolation was performed by
computing an average of the responses obtained at all injection sites,
weighted by the distance between the interpolated voxel and each
injection site. This ensured that the interpolated values were most
dependent on the responses of the nearest injection sites. In addition,
because of the nonhomogeneous sampling of the interpolated volume,
a mask was used to exclude voxels that were not close to at least one
injection point.
For each measurement location (left paw, right paw, proximal tail,
and distal tail), a three-dimensional (3D) volume representing re-
sponse latencies as a function of injection site was obtained using
interpolation. The responses obtained from the left and right paw were
merged, by expressing the location of the injection site as ipsilateral
(positive x-axis) vs. contralateral (negative x-axis) relative to the paw.
The interpolated 3D volume extended from 2 to 2 mm along the
x-axis, 1.5 to 1 mm along the y-axis, and 1 to 3.5 mm along
the z-axis (200 points along each dimension). For each voxel of the
volume, an interpolated latency was obtained by computing a
weighted average of all latency values:
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latencyx, y, z 
wilatencyi
N
The weight assigned for each latency value (wi) was determined by
the distance between the voxel (x, y, z) and the injection site (xi, yi, zi):
wi
1
xi x2 yi y2 zi z26
This weight is inversely proportional to the sixth power of the
distance. This ensured that at any given location of the interpolated
volume, interpolated latencies were more dependent on the latencies
of the nearest injection site. Because the 3D volume was not homo-
geneously sampled (i.e., injection sites were clustered in some regions
of the volume), a mask was used to exclude voxels, which were not
located at a distance 
0.5 mm of at least one injection point. Finally,
because injection at a large amount of sites did not elicit any response,
a second mask was computed to distinguish voxels located in regions
where injection elicited a response from voxels located in regions
where injection did not elicit a response after 55 min of recording.
After assigning a latency of 55 min to these trials, the second mask
was computed by taking all voxels of the interpolated volume having
interpolated latencies above an arbitrary interpolated latency value of
53.5 min.
Heat loss index. The skin is an interface between Tcore and Tamb
acting as a radiator. In addition to active changes secondary to
vasomotor tone of skin vessels, the temperature T of the skin can be
affected passively by either Tamb or Tcore. To cancel out these passive
changes, we computed the heat loss index (HLI)  (Tskin  Tamb)/
(Tcore  Tamb) as initially proposed by Székely (1986). The value of
HLI can vary between 0 and 1, representing complete vasoconstriction
(T  Tamb) and complete vasodilatation (T  Tcore), respectively
(Gordon et al. 2002; Romanovsky et al. 2002).
Analysis of vital signs. To study the systemic effects of muscimol
on MAP, HR, ETCO2, and Tcore with respect to the microinjection
sites, we divided the experiments in three groups on the basis of the
beginning time tmin of the ascending phase of vasodilatation: group 1:
tmin 
 15 min for all considered skin areas either on the tail or the
paws; group 2: tmin 
 15 min for at least one but not all the areas
considered on the tail or the hind paws; and group 3: tmin 	 15 min
for all considered skin areas either on the tail or the paws. The mean
of each variable during the control period was considered as the
reference level, and the temporal evolution was calculated in terms of
variation of this level, namely Tcore (°C), MAP (mmHg), HR
(°C), and ETCO2 (%).
Data processing and statistical analyses. The temporal evolution of
the mean skin temperature, MAP, and HR was synchronized and
measured with a 1-s time resolution. The corresponding time courses
were downsampled to a 1-min time resolution by averaging. Data were
expressed as means (confident interval 95%). The comparisons were
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Fig. 1. Procedure to analyze the muscimol-induced variations of skin temper-
ature. A and B, abscissa: time in minutes with reference to the end of the
microinjection. Ordinate: temperature in °C. The grey area corresponds to the
time intervals 
7.5 and 7.5–15 min postinjection, delimited by vertical dotted
lines. A: analysis of temperature variations observed from an ipsilateral hind
paw (Tpaw-ipsi). The thin yellow line is the temporal evolution of the temper-
ature recorded during the 5-min control period and the following 30 min
postinjection. The thick yellow line is the corresponding adjusted sigmoid
Boltzmann curve Tadj  Tmin  Tskin/{1  exp[ (t  tx)]/s}, with R2 
0.99 (equation at top left). The adjusted parameters of the function are shown
in red, namely the adjusted skin temperature during the control period
(Tmin  24.2°C), the adjusted maximal skin temperature at the end of the
process (Tmax  32.4°C), the amplitude of skin temperature variation
(Tskin  Tmax  Tmin  8.2°C), and the inflection point (tx, Tx  Tmin 
Tskin/2) [(8.8 min, 28.3°C)] of the sigmoid represented by a red point. The
beginning (tmin) and end (tmax) of the ascending phase of vasodilatation
were then calculated by considering the 10 and 90% percentiles of Tskin:
tmin  tx  Ln(1/0.1–1)  s1  4.9 min and tmax  tx  Ln(1/0.9 –1) 
s1  13.9 min, represented by white points. B: calculation of the
beginning of the ascending phase of vasodilatation observed from the
corresponding three other recorded zones (Tpaw-contra, Ttail-prox, and Ttail-
dist). The thin and thick curves represent the genuine and adjusted curves,
respectively. The green, dark blue, and light blue curves correspond to the
contralateral hind paw, proximal and distal parts of the tail, respectively
(corresponding equations provided at top left). Calculations of tmin were
made as in A, except for the proximal part of the tail for which a 15%
percentile was used in place of the 10% (see text). C: histogram showing
the distribution of the beginning of the ascending phase of vasodilatation
(tmin) for the ipsilateral hind paws, allowing the categorization into 3
groups: group 1: tmin 
 7.5 min; group 2: 7.5 
 tmin 
 15 min; group 3:
tmin 	 15 min.
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done using the Mann-Whitney U-test and the Friedman repeated-mea-
sures ANOVA on ranks test.
RESULTS
The paws and tail of the rat were successfully maintained in
vasoconstriction during the control period by preserving a
stable, homogeneous, and constant surrounding temperature
Twarm, adjusted to a few tenths degrees below Tcore, and by
keeping this temperature constant throughout the experiment.
Following a 15-min period of control in steady vasoconstric-
tion, muscimol (0.5 nmol, 50 nl) was injected over 60 s.
We will first describe in details a typical recording. Then the
effects of muscimol will be detailed with reference to the
injection sites determined postmortem. Emphasis will be made
on the comparison between hind paws (ipsilateral vs. contralat-
eral to the injection site). We seized the opportunity of the
large number of microinjection sites to build 3D mappings of
response latencies as a function of injection site, using inter-
polation. Results will also be synthesized by taking into ac-
count concomitant variations of MAP, HR, and Tcore. Finally,
the potential effect of muscimol on a widely used nociceptive
test, the tail-flick test, will be assessed by using the present
results to compute expected variations in tail-flick latency
(TFL) elicited by the effects of muscimol on both tail temper-
ature and Tcore.
A typical example of the effects of muscimol microinjection
within the RVM/rMR. An example of a thermographic film is
provided as Supplemental Video S1 (Supplemental Material
for this article is available online at the Journal website), from
which a series of seven images recorded during 30 min are
shown in Fig. 2A. These images correspond to a typical
example of a microinjection centered to the RMg, as deter-
mined following histological examination (Fig. 2H). Figure 2B
shows the temporal evolution of the temperature of 1) the hind
paws, ipsilateral (Tpaw-ipsi) and contralateral (Tpaw-contra) to the
microinjection site; 2) five sites on the tail; and 3) a small piece
of wood, indicator of Tamb. Figure 2C shows the temporal
evolution of Tcore. During the control period, Tamb and Tcore
were stable while the hind paws and tail were in vasoconstric-
tion with skin temperatures slightly above Tamb. Following the
injection of muscimol, a progressive increase of skin temper-
ature is observed, starting at the ipsilateral paw (Tpaw-ipsi: 4.9
min postinjection), followed by the proximal tail (Ttail-prox: 6.6
min), the distal tail (Ttail-dist: 11.6 min), and, finally, the
contralateral paw (Tpaw-contra: 12.6 min). The time courses of
Tpaw-ipsi and Tpaw-contra were similar, increasing by 8.2 and
7.4°C, within 7.7 and 8.0 min respectively, and remaining
stable afterwards. The temporal evolution of the temperature of
the tail was quite different, taking 26.6 min to achieve a 6.4°C
increase for Ttail-prox vs. 21.2 min to achieve a 7.8°C increase
for Ttail-dist. The intermediate parts of the tail showed a similar
evolution whose parameters spread out between those of the
extreme parts.
Shortly after vasodilatation of the ipsilateral hind paw, one
sees a decrease in Tcore (Fig. 2C) that was accentuated by the
later vasodilation of the tail and contralateral hind paw. Over-
all, Tcore was reduced by 0.8°C within the 30 min postinjection
period despite the active warming that remained stable all over
the experiment. The HLIs are shown in Fig. 2D for each site of
Tskin skin recording.
MAP (Fig. 2E) and HR (Fig. 2F) were also affected by
muscimol. Both parameters dropped and stabilized within 8
min, which is a few minutes earlier than the vasodilatation. At
30 min, the final MAP and HR were 36 and 20% less than
during the control period, respectively. These variations were
associated with a decrease of ETCO2 (Fig. 2G).
From such an example, one can infer that microinjection of
muscimol centered on the RMg is able to block the drive of the
sympathetic control of vasomotion of the hind paws and the
tail, leading to an increase in their skin temperature and a
subsequent decrease in Tcore. The effects were dominant on the
part of the body ipsilateral to the microinjection site. These
variations were associated with a decrease in MAP, HR, and
ETCO2.
Overall effect of muscimol microinjection within the RVM/
rMR on the vasomotion of the hind paws. During the control
period, both hind paws were vasoconstricted at a stable skin
temperature, close to Tamb. The microinjection of muscimol in
the RVM/rMR elicited an increase of the plantar skin temper-
ature, indicating increasing blood flow. This reaction always
started first in the ipsilateral hind paw. Following adjustment of
each individual curve to a sigmoid by a Boltzmann regression
(see Fig. 1, A and B), the experiments were divided in three
groups on the basis of the distribution of the beginning (tmin) of
the ascending phase of vasodilatation at the hind paw ipsilat-
eral to the microinjection site (Fig. 1C): group 1 (acute onset
group: tmin 
 7.5 min); group 2 (intermediate onset group:
7.5 
 tmin 
 15 min); and group 3 (late onset or no response
group: tmin 	 15 min). The corresponding temporal evolutions
of adjusted skin temperatures are shown in Fig. 3 for the three
groups. Regarding the two groups showing responses with
acute or intermediate onset, the ipsilateral and contralateral
curves were essentially parallel, but the response elicited in the
latter was postponed by 11–12 min. The ascending phase of
vasodilatation t was short lasting (in the 6–8 min range) and
large (in the 7–8°C/min range) and therefore steep (in the
1°C/min range). The corresponding numerical data are pro-
vided in Table 1.
Figure 4 shows the corresponding localization of the mus-
cimol microinjection sites reported on the atlas of the rat brain
by Paxinos and Watson (1986). For clarity of presentation, the
data related to the hind paws, ipsilateral and contralateral to the
microinjection sites, are shown on the Fig. 4, A and B, respec-
tively. The black, grey, and white circles represent microinjec-
tion sites related to experiments belonging to the first, second,
and third groups, respectively. Regarding the ipsilateral hind
paw, the most effective sites are located between planes 1.3
and 2.8 mm with reference to the interaural line, mainly in
raphe pallidus, inner layer of raphe magnus, and parapyramidal
nucleus (Fig. 4B). These points are surrounded laterally and
rostrocaudally by the second group (grey symbols), often
localized in the outer layer of the raphe magnus. The nonre-
active regions are outside these zones. The effects of microin-
jection on the contralateral hind paw (Fig. 4A) were very much
dependent on its proximity to the midline. Microinjections
distant from the midline by 
0.1 mm exhibited an acute onset
effect, and those by 
0.3 mm an intermediate onset effect.
We seized the opportunity of the large number of microin-
jection sites to build a 3D mapping of response latencies as a
function of injection site, using interpolation (Fig. 5). Since the
effects were clearly lateralized, the responses obtained from
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the left and right paw were merged, by expressing the location
of the injection site as ipsilateral (positive x-axis) vs. contralat-
eral (negative x-axis) relative to the paw. The earliest responses
latencies were observed between planes z  1.3 and z 
2.8 mm both from the midline (raphe pallidus and raphe
magnus) and a more lateral part centered on the lateral para-
gigantocellular nucleus (LPGi) and the parapyramidal nucleus
(PPy).
Overall effect of muscimol microinjection within the RVM/
rMR on the vasomotion of the tail. During the control period,
the tail was vasoconstricted, with a decreasing thermal gradient
from Ttail-prox to Ttail-dist [27.1 (26.9–27.3) vs. 24.9 (24.7–
25.1)°C; P 
 0.001]. The microinjection of muscimol within
the RVM/rMR elicited an increase of the tail skin temperature.
However, a proximal-distal gradient was also seen regarding
the reactivity of the tail. Knowing these gradients, we analyzed
the proximal and distal parts of the tail, separately, using the
type of grouping already made but based on the starting point
of the acute ascending phase of vasodilatation on the distal part
of the tail [1st group (acute onset group): 0 
 tmin
 7.5 min;
2nd group (intermediate onset group): 7.5 
 tmin 
 15 min;
and 3rd group (late or none reactive): tmin	 15 min], following
sigmoidal adjustment of each individual. The corresponding
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Fig. 2. Example of effects elicited by muscimol microinjection in the rostral
ventromedial medulla (RVM). A: example of pictures taken at 0, 5, 10, 15, 20,
25, and 30 min postinjection of a thermographic movie recorded with a 320 
240 pixel resolution (see the corresponding Supplemental Video S1). The false
color scale of temperature is shown at right. B: temporal evolution of the
temperatures recorded during the 5-min control and 30 min postinjection
periods. Abscissa: time in minutes. Ordinate: temperature in °C. The 8
analyzed zones (10 pixels each) are indicated on the drawing at right. Tpaw-ipsi
(yellow) and Tpaw-contra (green) corresponds to the skin temperature of the ipsi-
and contralateral hind paw, respectively. Ttail-prox (dark blue) and Ttail-dist (light
blue) corresponds to the skin temperatures of the proximal and distal part of the
tail, respectively; there are 3 additional intermediate blue sites between these
2 sites. Tamb (brown) corresponds to the ambient temperature measured from
a small piece of wood. Note the stability of the control period in vasoconstric-
tion with skin temperatures near Tamb. Following the microinjection, the
ipsilateral hind paw skin temperature raised first, followed by the proximal and
distal parts of the tail and at last the contralateral hind paw. C: temporal
evolution of core temperature (Tcore). Abscissa: time in minutes. Ordinate:
temperature in °C. Note the decrease in Tcore, starting shortly after the rise of
Tpaw-ipsi. D: corresponding heat loss index [HLI  (Tskin  Tamb)/(Tcore 
Tamb) (Romanovsky et al. 2002)] for the 7 skin areas considered. E: temporal
evolution of mean arterial pressure (MAP). Abscissa: time in minutes. Ordi-
nate: MAP in mmHg. Note the slight transitory increase in MAP shortly after
the microinjection, followed by a sustained drop and then a progressive
stabilization after 8 min postinjection. F: temporal evolution of heart rate (HR).
Abscissa: time in minutes. Ordinate: HR in beat per minute (bpm). Note the
slight transitory increase in HR shortly after the microinjection, followed by a
sustained drop and then a progressive stabilization after 9 min postinjection. G:
temporal evolution of ETCO2. Abscissa: time in minutes. Ordinate: end tidal
CO2 (ETCO2) in %. Note the parallel changes in E, F, and G. H: localization
of the site of injection drawn on a frontal section of the brain in plane2.3 mm
caudal to the interaural line. The center of the injection site is located 0.3 mm
lateral to the midline and 0.4 mm below the interaural line. 7, Facial nucleus;
GiA, gigantocellular reticular nucleus pars alpha; ml, medial lemniscus; PPy,
parapyramidal nucleus; py, pyramidal tract; RMg, raphe magnus nucleus; RPa,
raphe pallidus nucleus.
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Fig. 3. Temporal evolution of the skin temperature recorded from the hind
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See text and Table 1.
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temporal evolutions of adjusted skin temperatures are shown in
Fig. 6 for the three groups. Regarding the first two groups, the
corresponding numerical data are provided in Table 1. By
comparison with the paws the process was slower (in the
0.3–0.5°C/min range) and less pronounced (in the 4–6°C
range), possibly because we recorded the dorsal facet of the tail
(see DISCUSSION).
Figure 7 shows the corresponding localization of the
muscimol microinjection sites for the proximal (Fig. 7A)
and the distal (Fig. 7B) parts of the tail. Again, the black
grey and white symbols represent the acute, intermediate,
and late or none reactive group respectively. The black
symbols are located mainly between planes 1.3 and 2.8
mm, close to the midline, in the raphe pallidus and raphe
magnus. The grey symbols surround the black ones and are
located in the raphe magnus and parapyramidal region. In
these two groups, the proximal and distal parts of the tail
reacted concomitantly. Overall, the proximal part of the tail
was more responsive to the microinjection; in particular, one
can see several points from which a vasodilatation was
elicited on the proximal but not on the distal part of the tail,
at least within the 15-min early period. Most of these points
were however, located in the raphe magnus and parapyra-
midal nucleus.
Figure 8 represents the 3D mapping of response latencies
tmin as a function of injection site. For both the proximal (Fig.
8A) and the distal (Fig. 8B) parts of the tail, the earliest
response latencies were observed between planes z1.3 and
z  2.8 mm from the midline (raphe pallidus and raphe
magnus) and a more lateral part. Interestingly, the lateral part
centered on the parapyramidal nucleus was restricted to planes
z2.3 to2.8 mm without any obvious participation of the
lateral paragigantocellular nucleus.
Comparison of heat loss indexes in various vasomotor
states. The potential extent of skin temperature variations was
physically restricted to the Tamb-Tcore range. In terms of ther-
moregulation, these changes are best described using the Heat
Loss Index as it eliminates the passive changes and range
limitation due to any Tamb and Tcore variations (Gordon et al.
2002; Romanovsky et al. 2002; Székely 1986): HLI (Tskin
Tamb)/(Tcore  Tamb). Table 2 compares results of skin tem-
perature, converted in terms of HLI, obtained in the present
study (acute onset group 1, black symbols) to previous exper-
iments performed on anesthetized rats maintained in thermo-
neutral conditions (El Bitar et al. 2014a). The HLI values in the
control period of the present study were close to those recorded
during vasoconstrictions in our previous study and identical in
terms of ranking (Ttail-dist
 Tpaw-ipsi
 Ttail-prox). However, the
HLI values following muscimol microinjection were 20–25%
lower than the HLI seen during the maximal physiological
vasodilatation achieved during thermoneutrality. This observa-
tion suggests that the ongoing hind paws and tail fiber sympa-
thetic activity was not completely silenced following the mus-
cimol microinjections, in spite of an apparent ceiling effect.
Overall results, including the effects on vital signs. To
homogenize the results for further analyzes, the experiments
were reorganized in three new groups, again on the basis of the
onset time tmin of the ascending phase of vasodilatation (Fig.
9). The first includes experiments where tmin was 
 15 min for
all considered skin areas either on the tail or the paws (black
circles in Fig. 9A). They were located between planes0.8 and
2.8 mm, not more lateral than 0.3 mm from the midline,
mainly in the inner part of raphe magnus and raphe pallidus.
The second includes experiments where tmin was 
 15 min for
at least one but not all the areas considered on the tail or the
hind paws (grey circles in Fig. 9A). They were located in the
raphe magnus and parapyramidal area, surrounding the preced-
ing group. The third group includes experiments where tmin
was 	 15 min for all considered skin areas either on the tail or
the paws (white circles in Fig. 9A). The corresponding effects
of microinjection of muscimol on Tpaw-ipsi, Tpaw-contra, Ttail-prox,
and Ttail-dist are summarized in Fig. 9, B, C, D, and E,
respectively.
Figure 9F shows the concomitant effects on Tcore. There was
no statistical difference among the three groups concerning
Tcore during the control period (P  0.94). After the muscimol
Table 1. Results of paws (see Fig. 3) and tail (see Fig. 6)
Tmin, °C Tskin, °C tmin, min tx, min t, min Tskin/t, °C/min
Paw
Ipsilateral
Group 1 25.4 (25.2–25.7) 7.4 (7.2–7.7) 3.6 (3.4–3.8) 6.6 (7.4–5.8) 6.6 (7.4–5.8) 1.2 (1.0–1.6)
Group 2 25.4 (25.2–25.7) 7.7 (7.4–8.0) 11.3 (11.2–11.5) 15.3 (16.0–14.6) 7.9 (6.7–9.0) 7.9 (6.7–9.0)
Contralateral
Group 1 25.6 (25.5–25.8) 7.2 (7.0–7.4) 14.6 (12.8–16.3)* 18.0 (15.8–20.2)* 6.8 (5.9–7.7) 1.1 (0.9–1.3)
Group 2 25.4 (25.3–25.6) 7.9 (7.6–8.2) 23.5 (22.0–25.0)* 27.8 (29.6–25.9)* 8.5 (7.8–9.2) 0.9 (0.8–1.0)
Tail
Proximal
Group 1 27.7 (27.4–28.0) 4.4 (4.1–4.7)† 2.4 (2.4–2.5)† 8.1 (8.9–7.2) 14.2 (11.9–16.5)† 0.3 (0.2–0.4)†
Group 2 27.7 (27.3–28.2) 4.4 (4.0–4.9)† 8.2 (8.1–8.4)† 16.1 (16.9–15.3) 15.7 (13.7–17.7)† 0.3 (0.2–0.4)†
Distal
Group 1 25.2 (25.0–25.5) 5.6 (5.2–6.0)† 2.4 (2.0–2.8)† 8.6 (7.1–10.2)† 14.7 (11.2–18.2)† 0.4 (0.3–0.5)†
Group 2 25.4 (25.0–25.8) 6.2 (5.7–6.7)† 11.2 (11.0–11.4) 17.5 (18.6–16.4)† 12.5 (10.7–14.4)† 0.5 (0.4–0.6)†
Results (expressed as means  confident interval 95%) obtained following Boltzmann sigmoid regression of individual curves of skin temperature following
microinjections of muscimol (see Fig. 1). For both the paws and the tail, the experiments were divided in 3 groups on the basis of the beginning time tmin of
the ascending phase of vasodilatation. Group 1: tmin 
15 min for all skin areas; group 2: tmin 
15 min for at least 1 skin area; group 3 (not shown): tmin 	15
min for all skin areas (see Fig. 3 and 6). tx, Abscissa of the inflection point of the sigmoid; t, duration of the ascending phase of vasodilatation; Tmin, adjusted
skin temperature during the control period; Tskin, amplitude of skin temperature variation; Tskin/t, speed of warming. The regression coefficients R2 of the
adjusted curves were always highly significant (	 0.98). *P 
 0.01, with respect to the corresponding value of the ipsilateral paw. †P 
 0.05, with respect to
the corresponding value of the ipsilateral paw.
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injection, the mean temperatures diverged strongly with pro-
gressive drops for the first and second group. The effects of
muscimol microinjections on MAP, HR, and ETCO2 are pre-
sented in Fig. 9, G, H, and I, respectively. For all three groups,
we report a transitory increase of MAP and HR in the first
minute following the microinjection of muscimol. Thereafter,
the curves declined slowly and slightly till the end of the
experiments. Regarding the first two groups, the corresponding
numerical data are provided in Supplemental Table S1. These
results are in line with previous reports in anesthetized rats
following microinjection of muscimol in the RVM/rMR, de-
scribing slight or nonsignificant decreases in MAP, HR, and
ETCO2 (Bernard et al. 2008; Blessing and Nalivaiko 2001;
Nakamura and Morrison 2007; Tanaka et al. 2007; Zaretsky et
al. 2003a,b). Note that our recordings were made under an
anesthetic regime that preserves withdrawal reflexes while
most earlier reports were obtained with deeper regimes that
could have masked the effects reported here.
Modeling the effect of muscimol injection within the RVM/
rMR on the tail-flick test. In a previous study, we proposed and
verified experimentally a simple model to compute the ex-
pected TFL of a rat exposed to a source of radiant heat applied
onto the tail (Benoist et al. 2008). The model takes into account
the power of the radiant heat source, the initial skin tempera-
ture, Tcore, and the site of stimulation on the tail and has been
applied successfully to reconstruct TFLs following a condi-
tioned stress response (Carrive et al. 2011). Here, the model
was used to compute the predictable variations of TFL intro-
duced by muscimol. Decisional and motor latencies were
estimated to be 134 and 4 ms, respectively (Benoist et al.
2008). Considering a site of stimulation on the mid-tail, the
distance to the dorsal horn entry zone is 200 mm. The model
provides the following equation for the expected tail-flick
latency: TFL (s)  [(36.8  0.73  Tmid-tail)2/  90/(0.041 
Tcore  0.47)  110/(0.041  Tmid-tail  0.47)  138]/1,000
where  is the slope of the squared temperature variation (in
°C2/s) generated by the power of the radiant heat source.
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Let us recall at this point that, when the skin is exposed
to a constant power source of infrared radiation, the tem-
perature increases with the square root of time, according to
the law of radiant heat transfer T  Tmid-tail  a.t0.5 or
expressed in terms of temperature variation T  Tmid-tail 
a.t0.5. This quadratic relationship becomes linear in t by
squaring the two terms of the equation: (T  Tmid-tail)2 
a2.t  .t where  is the slope of the squared temperature
variation generated by the power of the radiant heat source
[see Fig. 2A in Benoist et al. (2008)]. The predictive model
of TFL was fully verified following variations of the radiant
heat source (i.e., ) or the basal temperature of the skin (i.e.,
Tmid-tail here) [see Fig. 8 in Benoist et al. (2008)]. In the
classical tail-flick test, the principal source of variation
introduced by experimenters is the power of the electrical
bulb used for heating the skin of the animal. The investiga-
tor adjusts the radiant heat emission with a rheostat to
achieve a predetermined TFL in the control situation, most
commonly in the 2- to 4-s range (Le Bars et al. 1999, 2009).
In the model, such latencies are achieved for  in the
0.08 – 0.2°C2/s.
The model was applied to the data of animals in which the
beginning of the ascending phase of vasodilatation was 
15
min either on the tail or the paws (black group in Fig. 9).
The model foretells a 30 –35% decrease of the TFL, 30 min
following muscimol administration (Fig. 10). It appears
therefore that, regardless of any other additional possible
causes, the vasodilatation of the tail is a major source of
variation of the TFL following muscimol administration in
RVM/rMR.
DISCUSSION
Muscimol was injected in the lower brainstem with the aim
of assessing the role of the RVM/rMR on the control of
sympathetic drive to the tail and hind paws. Microinjections
within this brainstem region increased the skin temperature of
the hind paws and tail as a result of reduced vasomotor tone.
The effects were dominant on the hind paw ipsilateral to the
microinjection site. Increased heat loss through vasodilatation
of the tail and paws was associated with a drop of Tcore and
slight decreases of MAP, HR, and ETCO2.
Following some technical considerations regarding the mi-
croinjection procedure, we will discuss the following points: 1)
general findings; 2) lateral localization of effective sites; 3)
rostrocaudal localization of effective sites; and 4) pharmaco-
logical manipulations of RVM/rMR in pain studies.
Technical considerations regarding the microinjection
procedure. The kinetic and volume of efficient microinjection
are determined by numerous factors: the concentration, rate of
delivery, and properties of both the drug (coefficient of diffu-
sion, binding, catabolism) and the tissue (volume fraction,
py
7
py
Gi A
RM g
R P a
Gi
7
7
PPy
py
Gi
py
py
1st group = 0-7 min 3rd group > 15 min
7
Gi A
RM g
R P a
Gi
py
RPa
B distal part of the tailA proximal part of the tail
Gi
7
PPy
py
Gi
7
py
py
Gi
py
py
py
68
172
144
PPyPPy
53
z = - 2.8 mm
z = - 2.3 mm
z = - 1.8 mm
z = - 1.3 mm
z = - 0.8 mm
z = - 3.3 mm
2nd group = 7-15 min
0 42 x (mm) 0 42 x (mm)
RPa
RMg
GiA
ml
GiA
RPa
ml
RMg
GiA
RPa
RMg
ml
ml
GiA
RPa
RMg
ml
RPa
RMg
RPa
RPa
RMg
GiA
ml
GiA
RPa
ml
RMg
GiA
RPa
RMg
ml
ml
GiA
RPa
RMg
ml
RPa
RMg
Fig. 7. Overall effects elicited by muscimol microinjection on the skin
temperature recorded from the tail. A: proximal part of the tail. B: distal part
of the tail. Symbols and abbreviations as in Fig. 4.
-15 0 15
group 1 (n = 14)
tmin < 7.5 min
group 2 (n = 18)
7.5 min < tmin < 15 min
group 3 (n = 128)
tmin > 15 min
muscimol (0.5 nmol, 50 nl)
30min
B
C
Δt ~ 13 min
Δt ~11-14 min
8
6
4
2
0
-2
8
6
4
2
0
-2
8
6
4
2
0
-2
ΔT
(°
C
)
ΔT
(°
C
)
ΔT
(°
C
)
A
Ttail-prox
Ttail-dist
Fig. 6. Temporal evolution of the skin temperature recorded from the tail,
following muscimol microinjections. Abscissa: time in minutes. Ordinate:
temperature variation in °C (mean  95% confidence interval). As indi-
cated at bottom left, dark blue and blue colors are data adjusted to a
Boltzmann sigmoid (see Fig. 1) from the skin temperature of the proximal
(Ttail-prox) and distal (Ttail-dist) part of the tail, respectively. The experiments
were divided in 3 groups on the basis of the distribution of the beginning
(tmin) of the ascending phase of vasodilatation on the distal part of the tail.
A: group 1: tmin 
 7.5 min. B: group 2: 7.5 
 tmin 
 15 min. C: group 3:
tmin 	 15 min. See text and Table 1.
781RVM CONTROL OF CUTANEOUS VASOMOTION
J Neurophysiol • doi:10.1152/jn.00695.2015 • www.jn.org
tortuosity) (Syková and Nicholson 2008). In nuclear and cor-
tical homogenous regions, drug distributions are typically
spherical or in the shape of drop (Bondareff et al. 1970; Martin
1991; Myers 1966).
In a “mapping” study aiming at demarcating a functional
region in the brain, both positive and negative results are
significant. A negative result obtained with a large dose is a
very convincing result in this respect. Considering the large
volume of the explored brain structure (roughly 3  4  2 
24 mm3), a compromise was necessary to both find significant
positive results with minimal doses and to avoid useless neg-
ative results. Studies on the involvement of these regions in
pain/nociception and thermoregulation have used muscimol
injections in the 10- to 1,000-pmol/60- to 1,000-nl ranges
(Bernard et al. 2008; Blessing and Nalivaiko 2001; Brink et al.
2006; Cao et al. 2004, 2010; Cerri et al. 2010; Fan et al. 2007.
Gilbert and Franklin 2001; Heinricher and Kaplan, 1991;
Martenson et al. 2009. Meng et al. 1998; Morrison 1999, 2003;
Nakamura and Morrison 2007, 2011; Ootsuka and McAllen
2005; Rathner et al. 2008; Vianna et al. 2008; Zaretsky et al.
2003a,b). Knowing that muscimol does not spread appreciably
because it is a potent ligand for neuronal and glial GABAA
receptors, we decided to use a small volume of injection
(50 nl  0.05 mm3, that is a 0.5 mm diameter for an ideal
sphere) but a relatively high concentration. This was supposed
to provide an effective radius of blockade in the 1-mm range
(Martin 1991; Martin and Ghez 1999; Malpeli 1999; Edeline et
al. 2002). Following similar microinjections using [3H]musci-
mol, autoradiographic analyses showed a spread 1.5 mm
from the injection site at 15 min (Edeline et al. 2002; Martin
1991). Martin and Ghez (1999) used glucose metabolism to
assess the extent of inactivation and observed a central core of
blockade (1-mm radius) surrounded by an extensive region
of reduced metabolism, possibly due to reduced synaptic ac-
tivity of neurons receiving projections from the core region. In
summary, muscimol binds strongly and diffuses slowly out-
ward at effective concentrations from the region immediately
inundated by the bulk flow (Malpeli 1999).
Since myelinated fiber bundles impede muscimol diffusion
(Allen et al. 2008), it is likely that the particular architecture of
the RVM/rMR with a predominance of rostrocaudal fibers and
a low neuronal density favors a rostrocaudal diffusion of the
product. In addition, the two paired bundles of myelinated
fibers that cover the brainstem floor, namely the pyramidal
tract and the medial lemniscus, constitute a strong diffusion
barrier. Accordingly, the postmortem examination of pon-
tamine spread revealed an elongated pattern of diffusion two
times longer in the rostrocaudal direction compared with the
coronal plane.
Using these microinjections, we were able to build response
maps on the basis of 160 experiments. Together with the small
volume of injection and the large number of negative sites of
injection (60%), this approach provided 1) an acute delineation
of the structures able to block sympathetic cutaneous vasocon-
strictor activity; 2) the possibility of a temporal analysis of
these effects; and 3) the resultant capacity of defining a brain
region as the core of effects, surrounded by intermediate and
then ineffective zones.
Because of such a large number of injection sites, we
introduced a new procedure to compute 3D interpolated maps
of response latencies and overall sympathetic blockade as a
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Fig. 8. Three-dimensional mapping of the tail response latencies tmin as a
function of injection sites. A: proximal part of the tail. B: distal part of the tail.
The interpolated response latencies are indicated by the false colors (scale
shown at bottom). They are adjusted on frontal sections of the brain from
interaural z  0.8 (top) to z  3.3 mm (bottom) with x and y being the
lateral and ventrodorsal coordinate, respectively, again with reference to the
interaural line. Symbols and abbreviations as in Fig. 5.
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function of injection site. The interpolation was performed by
computing an average of the responses obtained at all injection
sites, weighted by the distance between the interpolated voxel
and each injection site. This ensured that the interpolated
values were most dependent on the responses of the nearest
injection sites. In addition, because of the nonhomogeneous
sampling of the interpolated volume, a mask was used to
exclude voxels that were not close to at least one injection
Table 2. Summary of skin vasomotor tone
HLI During Vasoconstriction HLI During Vasodilation
Control period
(present study)
Vasoconstriction periods (El Bitar
et al. 2014a) P 30 min following muscimol
Vasodilation periods (El Bitar
et al. 2014a) P
Tpaw-ipsi 0.10 (0.10–0.11) 0.13 (0.09–0.16) 0.12 0.69 (0.65–0.74) 0.92 (0.85–0.98) 
 0.00001
Ttail-prox 0.24 (0.22–0.25) 0.23 (0.21–0.26) 0.64 0.62 (0.57–0.67) 0.77 (0.72–0.83) 
 0.0001
Ttail-dist 0.04 (0.04–0.04) 0.03 (0.01–0.05) 0.06 0.55 (0.46–0.63) 0.74 (0.69–0.80) 
 0.0001
Results are expressed in terms of heat loss index [HLI  (Tskin  Tamb)/(Tcore  Tamb)] (Gordon et al. 2002; Romanovsky et al. 2002; Székely 1986),
represented as means and their 95% confidence interval. Results obtained from current study are compared to a previous study in the extreme vasomotor tone
status, namely vasoconstriction and vasodilation. During vasoconstriction, there were no significant statistical differences between HLI observed in the 2 studies.
By contrast, the HLI for both hind paws and following muscimol microinjections were significantly lower than the HLI seen during the physiological vasodilation
elicited during thermoneutrality (El Bitar et al. 2014a).
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point. The obtained volumes provide an interesting mean to
assess the relationship between the effects of the injection and
the anatomical location of the injection.
General findings. Our results are largely in agreement with
earlier reports regarding the sympathetic drive of the tail.
Microinjection of glycine, GABA, or muscimol in the RVM/
rMR blocks the activation by cold or fever of sympathetic
fibers that innervate the tail (Blessing and Nalivaiko 2001;
Cerri et al. 2010; Korsak and Gilbey 2004; Ootsuka and
McAllen 2005; Ootsuka et al. 2004; Rathner et al. 2008;
Vianna et al. 2008). On the other hand, microinjection of
glutamate or bicuculline increases the activity of vasomotor
sympathetic nerves of the tail, thus decreasing the blood flow,
without affecting the mesenteric vascular bed (Blessing and
Nalivaiko 2001; Morrison 2001; Rathner and McAllen 1999).
Several aspects of our contribution should be highlighted.
The experimental conditions were close to those of thermo-
neutrality (El Bitar et al. 2014a). Twarm was adjusted to0.3°C
below Tcore. Demonstrating their vasoconstricted state, the
temperature of the distal part of the tail was very close to the
ambient temperature (0.7°C above Tamb). It then increased
by 6°C following the injection of muscimol in responsive
brainstem sites. In comparable experimental conditions, micro-
injection of GABA or muscimol in RVM/rMR blocks the
activity of the sympathetic fibers innervating the rat tail (Kor-
sak and Gilbey 2004; Ootsuka and McAllen 2005).
We have previously discussed (El Bitar et al. 2014a) that the
vasomotor tone of the dorsal facet of the tail is less reactive
than the ventral facet, notably because the ventral artery is
larger than the lateral arteries, while the ventral vein is thinner
than the lateral veins (Knoppers 1942; Thorington 1966; Wu et
al. 1995; Young and Dawson 1982). It follows that the tem-
peratures of the dorsal and ventral facets of the tail are identical
during vasoconstriction but shift by 3°C during full vasodi-
latation. The recorded effects from the tail were thus underes-
timated, compared with those seen on the hind paws.
A major novelty of our study was to include the paws to
these basic phenomenological observations. Such as for the
tail, the hind paws were in a stable vasoconstricted state, as
demonstrated by the fact that the temperature of the hind paws
was close to the ambient temperature (2–3°C above Tamb). This
increased by 7°C following the injection of muscimol in the
active sites. We have already discussed the involvement of the
paws in rat thermoregulation (El Bitar et al. 2014a). The feet
make up 10% of the total surface area of the body, slightly
more than the tail (Lin et al. 1979). It follows that the substan-
tial muscimol-induced vasodilatation of the paws contributed
significantly to Tcore drop (1°C within half an hour).
Our purpose was not to confirm well-documented notions.
We specifically aimed at mapping the brainstem regions that
contain the premotor sympathetic neurons that control the
vasomotor tone of the tail and hind paws because most models
of pain/nociception are based on behavioral responses elicited
by thermal stimulation (reviewed in Le Bars et al. 2001, 2009).
We undertook this large study because studies on pain/nocice-
ption have emphasized the RVM, which includes the nucleus
raphe magnus and the gigantocellular reticular nucleus pars
alpha (mainly at the level of the facial nucleus), while studies
on thermoregulation have emphasized a slightly shifted more
caudal region centered on the raphe pallidus. In addition, we
described in a previous work that neurons involved in pain/
nociception located in the brainstem are probably also impli-
cated in autonomic regulation, notably cutaneous vasomotion
(El Bitar et al. 2014b).
The results of the present study suggest that the regions
described as being involved in pain/nociception modulation
and the regions involved in thermoregulation are spatially
matched, at least functionally regarding the vasomotor tone of
the tail and hind paws.
Localization of effective sites in coronal planes. The most
effective sites were restricted to well-circumscribed regions.
Numerous negative microinjections sharpened the delineation.
Our observations regarding the tail are in keeping with the
mapping by Korsak and Gilbey (2004), who reported that
GABA microinjections in the region of raphe pallidus and
magnus markedly decreased the sympathetic cutaneous vaso-
constrictor activity in the dorsal collector nerves of the tail,
while injections more dorsal or lateral tended to produce either
a smaller decrease or have no effect. Blessing and Nalivaiko
(2001) also emphasized the raphe magnus, raphe pallidus, and
parapyramidal nucleus in this respect, although they did not
provide a graphical mapping of the effects.
Only microinjections in RMg, RPa, and PPy elicited a
vasodilatation in the ipsilateral hind paw within 
7.5 min, and
those distant from the midline by 
0.3 mm induced a vasodi-
latation in the contralateral hind paw within the same period.
These observations deserve two comments. First, within the
coronal plane, the lateral diffusion of muscimol was limited, as
expected. Second, projections of RVM/rMR cells are mainly
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Fig. 10. We proposed and verified experimentally a simple model for com-
puting the tail-flick latency (TFL) in the rat, taking into account the power of
the radiant heat source, the initial temperature of the skin, Tcore, or the site of
stimulation on the tail (Benoist et al. 2008). This model is used here to compute
the predictable variations of the TFL introduced by muscimol in the positive
cases of the present experiments. Since the decisional and motor latencies were
estimated 134 and 4 ms, respectively (Benoist et al. 2008) and considering a
site of stimulation on the mid-tail far-off the dorsal horn entry zone by 200
mm, the model provides the following equation giving the tail-flick latency:
TFL (s)  [(36.8  0.73  Tmid-tail)2/  90/(0.041  Tcore  0.47) 
110/(0.041  Tmid-tail  0.47)  138]/1,000, where  is the slope of the
squared temperature variation, witness of the power of the radiant heat source.
Experimental data are from the experiments where the beginning of the
ascending phase of vasodilatation was 
15 min either on the tail or the paws
(black group in Fig. 9); they include both the mean temperatures of the core
(Tcore, brown line) and the middle of the tail (Tmid-tail, blue line). In the control
situation, the model provides TFLs (red lines) in the 2–4 s range for  in the
0.08–0.2°C2/s range: the model foretells a 30–35% decrease of the TFL
following muscimol microinjections in the sites indicated by a black circle in
Fig. 9A.
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lateralized, predominantly controlling vasomotor tone of the
ipsilateral body side. Our results are in keeping with studies
showing that RVM/rMR neurons send axons towards the spinal
cord mainly through the ipsilateral dorsolateral funiculus (Bas-
baum and Fields 1979; Fields et al. 1995; Lefler et al. 2008;
Light 1985). Microinjections close to the midline also elicited
early vasodilatation of the tail, the most effective sites being
restricted to the same well-circumscribed regions. Neurons in
the PPy present morphological, histochemical (Helke et al.
1989; Lynn et al. 1991) and functional (Blessing and Nalivaiko
2000) properties similar to those of the RPa. Some authors
therefore consider PPy as part of RPa (e.g., Cano et al. 2003).
Interestingly, brainstem neurons activated both antidromi-
cally from the lumbar dorsolateral funiculus and by mild
cooling of the animal Tcore were found in both raphe pallidus
and magnus (Rathner et al. 2001). Such neurons could be
involved in the results presented here. However, there are other
control loops that regulate the central temperature through the
vessels in the hairy skin, the interscapular BAT, and the
fusimotor fibers to limb muscles, all being silenced by neuronal
inhibition of the raphe pallidus and/or magnus (McAllen et al.
2010). Although they all should have a sympathetic premotor
relay in these nuclei, these four sympathetic thermoeffector
outflows differ in terms of thermal thresholds, relative respon-
siveness to Tcore, patterns and driving by neural pathways and
thus probably do not “cross talk” at this level (McAllen et al.
2010; Nagashima et al. 2000; Ootsuka and McAllen 2006 ;
Romanovsky 2007; Tanaka et al. 2007). The relative contribu-
tion of single individual neurons to these functions remains an
open question.
Rostrocaudal localization of effective sites. Overall, the
injection sites that elicited the most widespread and early
latency vasodilation were located in the coronal planes poste-
rior to the interaural line by 1.3–2.6 mm. Eighty-five percent of
experiments where the vasodilatation of all areas either on the
tail or the paws occurred in 
15 min were found in these
regions. Again our observations agree with the report by
Korsak and Gilbey (2004) showing a similar rostrocaudal
extension of their effective sites for blocking by GABA the
sympathetic vasoconstrictor drive in the tail. Similarly, brain-
stem neurons both antidromically activated from the lumbar
dorsolateral funiculus and activated by mild cold were found in
the raphe nuclei between the coronal planes posterior to the
interaural line by 1.8–2.3 mm (Rathner et al. 2001).
Overall, the literature related to thermoregulation points to
coronal planes immediately rostral to the rostral pole of the
inferior olivary complex at the level of the caudal half of the
facial nucleus. This brainstem region is often referred as to the
rostral raphe pallidus, although it generally does include the
nucleus raphe magnus (e.g., Madden and Morrison 2003, 2005;
Morrison 1999, 2003; Morrison et al. 1999, 2000; Rathner et
al. 2008). In fact, very few studies were devoted to a systematic
mapping.
As pointed out by Nason and Mason (2004), it is unlikely
that a microinjection into any single nucleus in RVM/rMR will
affect neurons confined to that nucleus because these neurons
have large dendritic arbors that cross cytoarchitectonic bound-
aries (Gao and Mason 1997; Mason et al. 1990; Newman 1985;
Potrebic and Mason 1993). Blessing (2003) discussed the
conventional anatomical demarcation into RMg and RPa by
raising the following points. The delimitation of boundaries is
based particularly on the work of Taber et al. (1960) that
follows the atlas of Meessen and Olszewski (1949) for rabbits
and the atlas of Olszewski and Baxter (1954) for humans.
However, the rabbit atlas combines all the ventral midline
neurons in the rostral medulla and caudal pons as “RMg” and
does not use the term “RPa.” In contrast, the human atlas uses
“RPa” and not “RMg.” However, by convention, RMg in the
rat is more rostral and dorsal, and RPa is more caudal and
ventral (Paxinos and Watson 1986).
We noted that the HLIs following muscimol microinjection
were 20–25% lower than the HLI seen during the maximal
physiological vasodilatation achieved in rats maintained in
thermoneutral conditions (El Bitar et al. 2014a), suggesting
that the ongoing hind paws and tail fiber sympathetic activities
were not completly silenced following the microinjections, in
spite of a clear ceiling effect when microinjections were
effective. The most parsimonious explanation for this obser-
vation is the oblong geometry of the involved brainstem
structures, 12 times longer than the diameter of the injected
volume, preventing the drug to reach all structures potentially
involved in controling vasomotor tone.
In summary, there are morphological and functional reasons
to consider the RVM and rMR nuclei as a single RVM/rMR
entity, as already proposed by Mason et al. (2001, 2005a,b,
2006, 2011).
Is the RVM really specific for pain/nociception? Our study
shows, in the rat, a mutual covering of the regions involved in
thermoregulation (at least, regarding the vasomotor tone of the
tail and hind paws) with those reported as being specifically
involved in pain/nociception.
In spite of several warnings initiated by T. Lovick and P.
Mason (Le Bars et al. 2001; Lefler et al. 2008; Lovick 1997;
Mason 2001, 2005a,b, 2006, 2011, 2012), the specificity of the
RVM regarding the control of pain/nociception mechanisms is
repeatedly put forward or assumed (e.g., Fields et al. 2006;
Heinricher and Ingram 2008; Basbaum et al. 2009; Heinricher
et al. 2009). RVM neurons do not only project towards the
dorsal horn of the spinal cord (Fields and Basbaum 1978,
1999), but also to the intermediolateral cell column, with a high
degree of collateralization in both the rostrocaudal and dorso-
ventral axes (Bacon et al. 1990; Basbaum et al. 1978; Hossaini
et al. 2012; Lefler et al. 2008; Loewy 1981; Morrison and
Gebber 1985).
Numerous neurons in RVM/rMR were identified as sympa-
thetic premotor neurons by early retrograde transsynaptic la-
beling with the pseudorabies virus (Smith et al. 1998; Strack et
al. 1989). Quantitative data, obtained from 6 days survival
experiments, revealed approximately five times more labeled
neurons in raphe magnus and gigantocellular reticular pars
alpha nuclei than within the raphe palidus nucleus (Smith et al.
1998). Smith et al. (1998) found the highest density at the level
of the facial nucleus, but the coronal planes facing the rostral
part of the facial nucleus were not represented. Therefore, the
neurons labeled in that study could have been mainly located in
the RVM/rMR at the level of facial nucleus, although we
cannot infer their rostral extent. However, it was stated more
recently that transneuronally labeled neurons are distributed
through the parapyramidal region, including all RVM/rMR
elements (Tóth et al. 2006), at least within the coronal planes
from 1.3 to 3.3 mm posterior to the interaural line (Nakamura
et al. 2004). Finally, cold exposure increases the expression of
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Fos immunoreactivity not only in RPa and PPy (Bonaz and
Taché 1994; Cano et al. 2003; Martinez et al. 2001; Morrison
et al. 1999) but also in RMg, between the coronal planes
posterior to the interaural line by 1.3–3.3 mm (Nakamura et al.
2004).
If one moves back to the literature related to nociception,
namely the so-called on- and off-cells recorded within the
medial brainstem, one is struck by the similar rostrocaudal
distribution of the sites, all pointing out the coronal planes
including the facial nucleus. Interestingly, Vanegas et al.
(1984) attempted to map on- and off-neurons that project to the
spinal cord and found that these were located in brain regions
1.9–2.7 mm posterior to the interaural line. In summary, the
most effective sites for blocking by muscimol the cutaneous
vasoconstrictor fibers matches exactly the brainstem sites
where on- and off-cells were recorded over the last years,
notably those projecting to the spinal cord.
Pharmacological manipulations of RVM/rMR in pain
studies. Administration of muscimol exclusively within RVM/
rMR results in a significant decrease in TFL while administra-
tion of the competitive GABAA receptor antagonist bicuculline
(but not the glycine receptor antagonist strychnine) induces an
increase of the TFL (Drower and Hammond 1988; Gilbert and
Franklin 2001; Heinricher and Kaplan 1991; Heinricher and
Tortorici 1994; Nason and Mason 2004). Similar results have
been reported with paw withdrawal and hot-plate tests (Gilbert
and Franklin 2001; Martenson et al. 2009).
These increases or decreases of TFL are generally inter-
preted in terms of hypo- or hyperalgesia, respectively. How-
ever, other interpretations are conceivable, available, and ad-
visable. The tail-flick test does not achieve the criterion of
construct validity because it does not effectively measure the
targeted construct, i.e., a quantitative nociceptive response,
presumed to reflect an animal’s perception of pain (Le Bars et
al. 2001, 2009). Indeed, the reaction time measured in the
conventional tail-flick test (and all other tests using conven-
tional progressive heating) is the sum of 1) the time to achieve
the threshold for the behavioral reaction and 2) the behavioral
latency (Benoist et al. 2008; Pincedé et al. 2012). If the
reaction time is the only measured end point, there is no way
of knowing whether the variation was produced by changes of
either the basal skin temperature or the threshold temperature
or both. Using a simple model for computing the TFL in the
rat, taking into account the power of the radiant heat source, the
initial skin temperature, Tcore, and the site of stimulation on
the tail (Benoist et al. 2008), we predicted that the change in
tail temperature 15 min after effective muscimol injection
would lead to a 30–35% reduction of the TFL. Interestingly,
Heinricher and Kaplan (1991) described a decrease of the TFL
of 30% at 12 min postinjection of muscimol (50 ng; 0.5 l),
maintained throughout the half an hour observation period, a
finding reproduced by Meng et al. (1998). Both observations
match remarkably the predicted variations of TFL related to
changes in baseline skin temperature. Interestingly, Tjølsen
and Hole (1997) attributed the reduction of TFL following
lesions of the raphe-spinal serotoninergic system to the in-
crease in skin temperature.
It should be noted that such considerations are not restricted
to the tests based on the utilization of thermal stimuli. For
example, the vasodilatation of the paws induced by high Tamb
exacerbates the second phase of the formalin test (Rosland
1991; Tjølsen et al. 1992). It follows that the increased respon-
siveness to formalin injection following muscimol administra-
tion in RVM/rMR (Gilbert and Franklin 2001) could also be
largely due to the unavoidable vasodilatation.
Conclusion. The functional blockade of the RVM/rMR by
muscimol elicits an important increase of skin temperature of
the paws and tail, eliciting a reduction of Tcore. The effective
zones match very exactly the brain regions defined as specif-
ically devoted to the control of nociception. Because changes
in skin temperature can have a strong effect on the usual tests
of pain using radiant heat such as the TFL, our results indicate
that the evidence that pharmacological manipulations of RVM/
rMR modulate pain-specific descending modulatory pathways
could, actually, be explained by unaccounted changes in vaso-
motor tone.
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